Literature DB >> 20967843

Modulatory effect of the SLC9A3 gene on susceptibility to infections and pulmonary function in children with cystic fibrosis.

Ruslan Dorfman1, Chelsea Taylor, Fan Lin, Lei Sun, Andrew Sandford, Peter Paré, Yves Berthiaume, Mary Corey, Peter Durie, Julian Zielenski.   

Abstract

In cystic fibrosis (CF), CFTR dysfunction leads to salt and water imbalance across airway epithelia, depleted surface liquid layer, and impaired mucociliary clearance. This provides optimal conditions for chronic bacterial infections leading to excessive inflammation and progressive obstructive lung disease. We hypothesized that other epithelial channels affecting salt balance across the airways may play a role in the susceptibility to bacterial infections and modulate severity of CF lung disease. The SLC9A3 gene encoding a Na(+) /H(+) exchanger was demonstrated to be a modifier intestinal disease in a murine model of CF. We examined the potential role of SLC9A3 as a modifier of CF lung disease severity. We analyzed 11 SLC9A3 gene variants for association with age of first Pseudomonas aeruginosa infection and lung function in children with CF. The T allele of an intronic variant in the SLC9A3 gene (rs4957061) was significantly (P = 0.02) associated with earlier acquisition of Pseudomonas infection in a cohort of 1,004 pediatric patients. Analysis of lung function in a subset of these patients (752) revealed that patients homozygous for the T allele had substantially reduced lung function and accelerated rate of decline. Although the functional basis for the modulatory effects of this SLC9A3 variant on CF lung disease remains to be elucidated, altered function of the Na(+) /H(+) exchanger may further deplete the airway liquid surface, thereby enhancing susceptibility to Pseudomonas infections and worsening the severity of lung disease.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20967843     DOI: 10.1002/ppul.21372

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  17 in total

1.  DNA methylation in nasal epithelium, atopy, and atopic asthma in children: a genome-wide study.

Authors:  Erick Forno; Ting Wang; Cancan Qi; Qi Yan; Cheng-Jian Xu; Nadia Boutaoui; Yueh-Ying Han; Daniel E Weeks; Yale Jiang; Franziska Rosser; Judith M Vonk; Sharon Brouwer; Edna Acosta-Perez; Angel Colón-Semidey; María Alvarez; Glorisa Canino; Gerard H Koppelman; Wei Chen; Juan C Celedón
Journal:  Lancet Respir Med       Date:  2018-12-21       Impact factor: 30.700

2.  Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities.

Authors:  Weili Li; David Soave; Melissa R Miller; Katherine Keenan; Fan Lin; Jiafen Gong; Theodore Chiang; Anne L Stephenson; Peter Durie; Johanna Rommens; Lei Sun; Lisa J Strug
Journal:  Hum Genet       Date:  2013-09-22       Impact factor: 4.132

3.  Pseudomonas aeruginosa in the Cystic Fibrosis Lung.

Authors:  John King; Ronan Murphy; Jane C Davies
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Na+/H+ Exchangers Are Required for the Development and Function of Vertebrate Mucociliary Epithelia.

Authors:  Dingyuan I Sun; Alexia Tasca; Maximilian Haas; Grober Baltazar; Richard M Harland; Walter E Finkbeiner; Peter Walentek
Journal:  Cells Tissues Organs       Date:  2018-10-09       Impact factor: 2.481

5.  Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis.

Authors:  Lei Sun; Johanna M Rommens; Harriet Corvol; Weili Li; Xin Li; Theodore A Chiang; Fan Lin; Ruslan Dorfman; Pierre-François Busson; Rashmi V Parekh; Diana Zelenika; Scott M Blackman; Mary Corey; Vishal K Doshi; Lindsay Henderson; Kathleen M Naughton; Wanda K O'Neal; Rhonda G Pace; Jaclyn R Stonebraker; Sally D Wood; Fred A Wright; Julian Zielenski; Annick Clement; Mitchell L Drumm; Pierre-Yves Boëlle; Garry R Cutting; Michael R Knowles; Peter R Durie; Lisa J Strug
Journal:  Nat Genet       Date:  2012-05       Impact factor: 38.330

Review 6.  Human Molecular Genetics and the long road to treating cystic fibrosis.

Authors:  Ann Harris
Journal:  Hum Mol Genet       Date:  2021-10-01       Impact factor: 5.121

7.  Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.

Authors:  Mary J Emond; Tin Louie; Julia Emerson; Jessica X Chong; Rasika A Mathias; Michael R Knowles; Mark J Rieder; Holly K Tabor; Debbie A Nickerson; Kathleen C Barnes; Lung Go; Ronald L Gibson; Michael J Bamshad
Journal:  PLoS Genet       Date:  2015-06-05       Impact factor: 5.917

8.  A Joint Location-Scale Test Improves Power to Detect Associated SNPs, Gene Sets, and Pathways.

Authors:  David Soave; Harriet Corvol; Naim Panjwani; Jiafen Gong; Weili Li; Pierre-Yves Boëlle; Peter R Durie; Andrew D Paterson; Johanna M Rommens; Lisa J Strug; Lei Sun
Journal:  Am J Hum Genet       Date:  2015-07-02       Impact factor: 11.025

9.  Genetic influences on cystic fibrosis lung disease severity.

Authors:  Colleen A Weiler; Mitchell L Drumm
Journal:  Front Pharmacol       Date:  2013-04-23       Impact factor: 5.810

10.  Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis.

Authors:  Harriet Corvol; Scott M Blackman; Pierre-Yves Boëlle; Paul J Gallins; Rhonda G Pace; Jaclyn R Stonebraker; Frank J Accurso; Annick Clement; Joseph M Collaco; Hong Dang; Anthony T Dang; Arianna Franca; Jiafen Gong; Loic Guillot; Katherine Keenan; Weili Li; Fan Lin; Michael V Patrone; Karen S Raraigh; Lei Sun; Yi-Hui Zhou; Wanda K O'Neal; Marci K Sontag; Hara Levy; Peter R Durie; Johanna M Rommens; Mitchell L Drumm; Fred A Wright; Lisa J Strug; Garry R Cutting; Michael R Knowles
Journal:  Nat Commun       Date:  2015-09-29       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.